JP2023513249A5 - - Google Patents
Info
- Publication number
- JP2023513249A5 JP2023513249A5 JP2022548433A JP2022548433A JP2023513249A5 JP 2023513249 A5 JP2023513249 A5 JP 2023513249A5 JP 2022548433 A JP2022548433 A JP 2022548433A JP 2022548433 A JP2022548433 A JP 2022548433A JP 2023513249 A5 JP2023513249 A5 JP 2023513249A5
- Authority
- JP
- Japan
- Prior art keywords
- tablet
- omecamutib
- tablet according
- coating film
- mecarbir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062972506P | 2020-02-10 | 2020-02-10 | |
| US62/972,506 | 2020-02-10 | ||
| PCT/US2021/017429 WO2021163172A1 (en) | 2020-02-10 | 2021-02-10 | Omecamtiv mecarbil tablet |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023513249A JP2023513249A (ja) | 2023-03-30 |
| JP2023513249A5 true JP2023513249A5 (https=) | 2024-02-08 |
| JP7696353B2 JP7696353B2 (ja) | 2025-06-20 |
Family
ID=74858801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548433A Active JP7696353B2 (ja) | 2020-02-10 | 2021-02-10 | オメカムチブメカルビル製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230090391A1 (https=) |
| EP (1) | EP4103159A1 (https=) |
| JP (1) | JP7696353B2 (https=) |
| CN (1) | CN115279349A (https=) |
| AU (1) | AU2021221106A1 (https=) |
| BR (1) | BR112022015457A2 (https=) |
| CA (1) | CA3168513A1 (https=) |
| IL (1) | IL295490A (https=) |
| WO (1) | WO2021163172A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2522579T3 (es) | 2004-06-17 | 2014-11-17 | Cytokinetics, Inc. | Compuestos, composiciones y métodos |
| SG11201507258PA (en) | 2013-03-14 | 2015-10-29 | Amgen Inc | Heterocyclic compounds and their uses |
| DK3645002T3 (da) | 2017-06-30 | 2024-12-16 | Amgen Inc | Fremgangsmåder til behandling af hjertesvigt med hjerte-sarkomer-aktivatorer |
| AU2018294254C1 (en) | 2017-06-30 | 2022-10-13 | Amgen Inc. | Synthesis of omecamtiv mecarbil |
| PT3594199T (pt) | 2018-07-09 | 2020-09-04 | Amgen Inc | 2-fluoro-3-nitrotolueno cristalino e processo para a sua preparação |
| MA53226A (fr) | 2018-08-17 | 2021-11-24 | Amgen Inc | Sel et formes cristallines d'omecamtiv mecarbil |
| WO2020131574A1 (en) | 2018-12-18 | 2020-06-25 | Amgen Inc. | Method of reducing aromatic nitro compounds |
| DK4243825T3 (da) | 2020-11-12 | 2025-12-01 | Amgen Inc | Omecamtiv mecarbil til behandling af hjerteinsattsvigt hos udvalgte patientgrupper |
| IL305751A (en) | 2021-03-10 | 2023-11-01 | Amgen Inc | SYNTHESIS OF OMECAMTIV MECARBIL |
| US20250161298A1 (en) * | 2022-02-22 | 2025-05-22 | Yale University | Methods of treating, ameliorating, or preventing heart failure, and methods of promoting heart muscle growth |
| US11986474B1 (en) | 2023-06-27 | 2024-05-21 | Cytokinetics, Incorporated | Methods for treating heart failure by administering cardiac sarcomere activators |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2419007T3 (es) * | 2005-12-15 | 2013-08-19 | Cytokinetics, Inc. | Ciertas entidades químicas, composiciones y procedimientos |
| SG11201507258PA (en) * | 2013-03-14 | 2015-10-29 | Amgen Inc | Heterocyclic compounds and their uses |
| US9895308B2 (en) * | 2013-03-14 | 2018-02-20 | Amgen Inc. | Heterocyclic compounds and their uses |
| DK3645002T3 (da) * | 2017-06-30 | 2024-12-16 | Amgen Inc | Fremgangsmåder til behandling af hjertesvigt med hjerte-sarkomer-aktivatorer |
-
2021
- 2021-02-10 US US17/798,531 patent/US20230090391A1/en active Pending
- 2021-02-10 WO PCT/US2021/017429 patent/WO2021163172A1/en not_active Ceased
- 2021-02-10 CN CN202180013878.7A patent/CN115279349A/zh active Pending
- 2021-02-10 EP EP21710140.1A patent/EP4103159A1/en active Pending
- 2021-02-10 IL IL295490A patent/IL295490A/en unknown
- 2021-02-10 JP JP2022548433A patent/JP7696353B2/ja active Active
- 2021-02-10 BR BR112022015457A patent/BR112022015457A2/pt unknown
- 2021-02-10 AU AU2021221106A patent/AU2021221106A1/en active Pending
- 2021-02-10 CA CA3168513A patent/CA3168513A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023513249A5 (https=) | ||
| CA2595033C (en) | Gastroresistant pharmaceutical formulations containing rifaximin | |
| RU2328274C2 (ru) | Препарат ламотриджин с контролируемым высвобождением | |
| CN101977593B (zh) | 包含弱碱性药物以及有机酸的给药系统 | |
| JP5918242B2 (ja) | リファキシミンを含む医薬処方物、それを得るための方法及び腸疾患を治療する方法 | |
| AU2008288106B2 (en) | Extended release compositions comprising mycophenolate sodium and processes thereof | |
| WO2008132710A2 (en) | Pharmaceutical nimodipine compositions | |
| AU2010242749A1 (en) | Orally disintegrating tablet compositions comprising combinations of non-opioid and opioid analgesics | |
| JP6148252B2 (ja) | 新規配合剤 | |
| HUP0201687A2 (en) | Oral administration form for administering a fixed tramadol and diclofenac combination | |
| KR101828630B1 (ko) | 구강 내 붕괴 정제 | |
| WO2005027876A1 (en) | Pharmaceutical compositions of benzimidazole and processes for their preparation | |
| KR20080037680A (ko) | 1-(4-클로로아닐리노)-4-(4-피리딜메틸)프탈라진 및 ｐｈ조절제를 포함하는 고체 제약학적 조성물 | |
| EP2698150A1 (en) | Oral solid preparation of compound antituberculosis drug and preparation method thereof | |
| WO2013181292A1 (en) | Nitisinone formulations | |
| EP3290023B1 (en) | Rivastigmine-containing sustained-release pharmaceutical composition | |
| US20090143362A1 (en) | Carbamazepine formulations | |
| JP5919173B2 (ja) | 徐放性塩酸アンブロキソール口腔内崩壊錠 | |
| CN100431526C (zh) | 一种酸敏感型药物的快速崩解片剂 | |
| KR20030051794A (ko) | 가수분해에 불안정한 조성물 | |
| HK1189504A (en) | Oral solid preparation of compound antituberculosis drug and preparation method thereof | |
| HK1189504B (en) | Oral solid preparation of compound antituberculosis drug and preparation method thereof | |
| IE20080345A1 (en) | A pharmaceutical composition |